These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 3523880

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Long-term graft survival with or without donor-specific transfusion in cyclosporine era in one haplo-identical living-related renal transplant recipients beyond the first year: a 19-year experience.
    Satoh S, Sugimura J, Omori S, Seino K, Fujizuka I.
    Tohoku J Exp Med; 2002 Aug; 197(4):201-7. PubMed ID: 12434995
    [Abstract] [Full Text] [Related]

  • 24. Randomized study comparing cyclosporine with azathioprine one year after renal transplantation-15-year outcome data.
    Joss N, Rodger RS, McMillan MA, Junor BJ.
    Transplantation; 2007 Mar 15; 83(5):582-7. PubMed ID: 17353778
    [Abstract] [Full Text] [Related]

  • 25. Outcome of renal transplants from pediatric donors <5 yr of age.
    El-Sabrout R, Buch K.
    Clin Transplant; 2005 Jun 15; 19(3):316-20. PubMed ID: 15877791
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Evidence demonstrating poor kidney graft survival when acute rejections are associated with IgG donor-specific lymphocytotoxin.
    Lobo PI, Spencer CE, Stevenson WC, Pruett TL.
    Transplantation; 1995 Feb 15; 59(3):357-60. PubMed ID: 7871565
    [Abstract] [Full Text] [Related]

  • 30. The effect of race and ethnicity on kidney allograft outcome.
    Katznelson S, Gjertson DW, Cecka JM.
    Clin Transpl; 1995 Feb 15; ():379-94. PubMed ID: 8794281
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Ten-year results of renal transplantation using only azathioprine and low-dose prednisolone as immunosuppression.
    McGeown MG, Doherty CC, Douglas JF, Donaldson RA, Hill CM, Kennedy JA, Loughridge WG, Middletown D.
    Clin Transpl; 1989 Feb 15; ():191-9. PubMed ID: 2487566
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Steroid withdrawal in kidney transplant recipients: is it a safe option?
    Sanfey H, Haussman G, Isaacs I, Ishitani M, Lobo P, McCullough C, Pruett T.
    Clin Transplant; 1997 Oct 15; 11(5 Pt 2):500-4. PubMed ID: 9361950
    [Abstract] [Full Text] [Related]

  • 37. Donor-specific transfusions have long-term beneficial effects for human renal allografts.
    Flye MW, Burton K, Mohanakumar T, Brennan D, Keller C, Goss JA, Sicard GA, Anderson CB.
    Transplantation; 1995 Dec 27; 60(12):1395-401. PubMed ID: 8545863
    [Abstract] [Full Text] [Related]

  • 38. Current strategy for donor-specific blood transfusions including a pre- and post transplant role for azathioprine.
    Salvatierra O.
    Transplant Proc; 1988 Dec 27; 20(6 Suppl 8):37-41. PubMed ID: 3201558
    [Abstract] [Full Text] [Related]

  • 39. Optimization of donor specific blood transfusion in kidney transplantation.
    Cheigh JS, Suthanthiran M, Stubenbord WT, Fotino M, Riggio RR, Schechter N, Stenzel KH, Rubin AL.
    Transplant Proc; 1987 Feb 27; 19(1 Pt 3):2250-1. PubMed ID: 2978891
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.